This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PPP2R1A Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PPP2R1A WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~65.3 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | Acetylated | |
| Caveat | Multi-subunit complex formation | |
| Regulation | IFN-γ-induced | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for PPP2R1A — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human Hela , Lane 2: human HepG2 , Lane 3: human A431 , Lane 4: monkey COS-7 , Lane 5: rat kidney , Lane 6: rat C6 , Lane 7: mouse NIH/3T3 . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-PPP2R1A antigen affinity purified polyclonal antibody (Catalog # A02822-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for PPP2R1A at approximately 65 kDa. The expected band size for PPP2R1A is at 65 kDa |
| Gel % | 10–12% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 65 kDa |
PPP2R1A is predicted at 65.3 kDa and typically runs as a single unmodified band near that size, lacking glycosylation, disulfide dimerization, or isoforms.
| Single band near 65 kDa | Represents full-length PPP2R1A at its predicted mass, since it carries no glycosylation, disulfide bonds, or cleaved propeptide |
| No mass shift despite acetylation marks | N-terminal N-acetylalanine and Lys280 N6-acetyllysine add negligible mass and do not produce a separate or shifted band |
| No additional isoform-sized bands | Only one annotated isoform exists, so extra bands from alternative splicing are not expected |
| Band present across cytoplasmic and nuclear/chromatin fractions | PPP2R1A localizes to cytoplasm, nucleus, chromosome/centromere, and lateral membrane, so it should be detectable in multiple subcellular fractions rather than absent from whole-cell lysate |
| No co-migrating higher-mass complex band under reducing SDS-PAGE | Although PPP2R1A assembles into the heterotrimeric PP2A holoenzyme with catalytic and regulatory subunits, denaturing/reducing conditions dissociate the complex so only the monomeric ~65 kDa subunit is seen |
| Predicted mass (65.3 kDa) | Sets the baseline expected migration position of monomeric PPP2R1A on SDS-PAGE |
| Absence of glycosylation | No sugar-driven mass addition or smearing above the predicted 65 kDa is expected |
| Absence of disulfide-linked homodimer | PPP2R1A runs as a monomer rather than showing a higher-mass dimer band even under non-reducing conditions |
| No signal peptide or propeptide cleavage | The full-length protein is already the mature form, so no smaller cleaved product is expected |
| Single annotated isoform | No additional isoform-derived bands at alternative molecular weights are expected |
| Heterotrimeric PP2A holoenzyme assembly | Under denaturing/reducing SDS-PAGE the complex dissociates, so co-migration with the catalytic or B subunit does not add mass to the PPP2R1A band |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | The chromosome/centromere-associated pool of PPP2R1A requires nuclease or high-salt extraction that standard RIPA lysis may under-recover | Use a nuclear/chromatin extraction buffer or benzonase treatment to solubilize centromere-bound PPP2R1A before loading |
| Band higher than expected | PPP2R1A remains bound to its PP2A holoenzyme partners (catalytic C and regulatory B subunits) if denaturation is incomplete | Fully boil samples in SDS sample buffer with reducing agent to dissociate the holoenzyme complex before loading |
| Multiple bands | Antibody cross-reactivity with co-purifying PP2A subunits or partial proteolytic degradation during lysate preparation | Include protease inhibitors during lysis and confirm the ~65 kDa band with a knockdown or knockout control |
| Weak or no signal | Low extraction efficiency from the chromosome/centromere or lateral membrane pools where PPP2R1A also resides | Increase lysate loading or optimize lysis conditions to capture membrane- and chromatin-associated fractions |
| Fragments below expected size | Proteolytic degradation during sample handling can clip the 65 kDa subunit, since PPP2R1A has no natural propeptide cleavage to account for smaller species | Add fresh protease inhibitors, keep samples cold throughout processing, and minimize freeze-thaw cycles |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for PPP2R1A, answered from its protein features.
BosterBio's PPP2R1A antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
For PPP2R1A Western blotting, we recommend a best-performing, extensively cited antibody that has undergone thorough validation, including orthogonal cross-validation against negative tissue controls and complementary methods, ensuring specific, reproducible detection you can trust.
Which to pick: Only one Boster anti-PPP2R1A antibody is catalogued here, A02822-2, which includes an actual Western blot validation image, making it the clear, ready-to-use choice for your PPP2R1A WB experiments without needing to compare alternatives.